Location History:
- Waltham, MA (US) (2002)
- Kenneth Square, PA (US) (2012)
- Radnor, PA (US) (2011 - 2013)
- Spring House, PA (US) (2015 - 2016)
- Brooklyn, NY (US) (2004 - 2018)
- Glenside, PA (US) (2020 - 2021)
- Kennett Square, PA (US) (2002 - 2024)
Company Filing History:
25 out of 410 
5 out of 144 
4 out of 31 
Years Active: 2002-2024
Title: Mark Hilary Cunningham: A Pioneer in Anti-IL-23 Therapeutics
Introduction: Mark Hilary Cunningham, a seasoned inventor based in Brooklyn, NY, has made significant contributions to the field of biotechnology through his innovative work. With 46 patents to his name, Cunningham's inventions primarily focus on the development of anti-IL-23 antibodies, showcasing his dedication to advancing medical therapies.
Latest Patents: Among his most recent patents are groundbreaking inventions including "Anti-IL-23 antibodies, compositions, methods and uses" and "Medical device for administering anti-IL-23 antibodies." The first patent details an anti-IL-23 antibody featuring isolated nucleic acids that encode at least one anti-IL-23 antibody, alongside vectors and host cells. This invention has vital applications in diagnostic and therapeutic compositions. The second patent describes a human anti-IL-23p19 antibody, with similar applications in diagnostics and therapeutics, highlighting Cunningham's role in the development of crucial medical devices targeting IL-23 pathways.
Career Highlights: Throughout his esteemed career, Mark Cunningham has worked with reputable companies such as Janssen Biotech, Inc. and Centocor, Inc., where he has played a crucial role in advancing therapeutic technologies. His extensive experience and innovation in the field further demonstrate his commitment to enhancing patient care through scientific research.
Collaborations: Throughout his journey, Cunningham has collaborated with notable colleagues, including Raymond W Sweet and Jacqueline Benson. These partnerships have allowed for the exchange of ideas and strategies, enhancing the scope and impact of their collective innovations.
Conclusion: Mark Hilary Cunningham stands out as an influential inventor in the biotechnology landscape, particularly in the realm of anti-IL-23 therapies. With a robust portfolio of patents and a history of impactful collaborations, his contributions continue to shape the future of medical treatments and therapeutic advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.